Howell lab develop novel ways to treat chronic bacterial infections
Bacterial biofilms represent a significant medical challenge due to the inability of therapeutics and the immune system to penetrate this protective coating. In a paper published online on May 20, 2016 in Science Advances, the Howell lab identified and produced two enzymes that the Gram-negative pathogen Pseudomonas aeruginosa use to synthesis two exopolysaccharides, to degrade this critical component of the biofilm. The enzymes, known as glycoside hydrolases, do […]